|
|
Testimonials
Comments from participants in recent Cell & Gene Therapy Forums included:
|
"Great range of topics. Excellent networking. Real case studies and perspectives most valuable"
Stephen Potter, Senior Vice President, Corporate Development, Genzyme Corporation
"A great forum providing a comprehensive overview of the key issues facing cell and gene therapy development"
Dr John St Clair Roberts, Vice President, Clinical & Regulatory, Intercytex
"A pleasure!!! This is by far the most focused, beneficial industry stem cell conference there is, and it gets better each year"
Dr Yaron Daniely, Vice President, Business Development, Gamida Cell Ltd
"Very good idea to introduce the financing aspects of CGT. Program timing is good"
Dr Eric Hammel, Managing Director, Centre Hospitalier Regional
|
"The case study descriptions, as with Michael Fox, were extremely informative. Reimbursement topics helpful. FDA attendance /presentations/and comments during Q&A are extremely informative. Lunch roundtable (interactive) discussions were very beneficial"
Darci White, Manager, Regulatory Affairs, Baxter Healthcare Corporation
"The schedule and breaks were great to allow networking and discussion time. Scheduling of Q&A time kept sessions on time. Very well organized. Like getting the CD of presentations"
Dr Gwendolyn Binder, Director, Translational Research Program Operations, University of Pennsylvania
|

©Copyright Phacilitate Limited 2010
|

»Click here to download the 2010 Main Announcement
» Click here to download the previous three Cell & Gene Therapy Forum Main Announcements

Over 50 sponsors and exhibitors participated in 2010.
Click here to find out how your company can participate.
|